JHEP Reports Internal Medicine
Biomarkers associated with efficacy of first-line nivolumab vs. sorafenib in advanced hepatocellular carcinoma: Results from the CheckMate 459 phase III trial
The publisher did not provide an abstract — full text is available via the link below.